CSL Ltd. (CMXHF)

126.11 +11.10 (+9.65%) USD  |  OTCM  |  Dec 12, 09:53
More

CSL EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for CMXHF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Alterity Therapeutics Ltd. Upgrade
Kazia Therapeutics Ltd. Upgrade
Immutep Ltd. Upgrade
Propanc Biopharma, Inc. Upgrade